Duluth Medical Technologies Inc. is a technology company.
Duluth Medical Technologies Inc. has raised $1.0M across 1 funding round.
Duluth Medical Technologies Inc. has raised $1.0M in total across 1 funding round.
No verifiable information exists on Duluth Medical Technologies Inc. as a distinct technology company based on available sources. Extensive searches across medical technology, healthcare equipment, and related sectors yield no matches for this entity, its products, leadership, or operations.[1][2][3][4][5]
The closest entities are established medtech firms like Agiliti, which provides medical equipment management services including innovative hospital beds (e.g., Essentia™ launched February 2025) and stretcher support surfaces to acute care facilities, serving over 10,000 U.S. sites by optimizing equipment lifecycle for better patient outcomes and cost savings.[1] Other prominent players include McKesson (pharmaceutical distribution and oncology solutions) and Alcon (eye care innovations), but none align with "Duluth" in name, location, or focus.[2][3]
No founding details, founders, or backstory for Duluth Medical Technologies Inc. appear in records. It may be a defunct, rebranded, or unindexed private entity, as no mentions surface in company databases, news, or career sites up to 2025.[1][2][3][4][5]
For context, comparable medtech firms like Agiliti have evolved into nationwide service providers with recent product launches (e.g., Adapt Line™ in December 2024), emphasizing local responsiveness and innovation in patient care equipment.[1] Alcon traces its roots over 75 years to global eye care leadership.[3]
Unable to identify unique aspects for Duluth Medical Technologies Inc. due to lack of data. No products, target markets, or competitive edges documented.[1][2][3][4][5]
Duluth Medical Technologies Inc. plays no discernible role, as it lacks presence in medtech trends like equipment optimization, precision diagnostics, or eye care innovation driving the 2025 healthcare ecosystem.[1][2][3][4][5]
Market forces favor firms riding digitization and patient-centric tech: Agiliti addresses equipment readiness amid rising HACs (hospital-acquired conditions); McKesson advances oncology via biopharma partnerships; Quest Diagnostics subsidiaries like Blueprint Genetics enable genetic testing across specialties.[1][2][4] Timing aligns with post-2024 demands for cost-efficient, AI-enhanced medtech amid aging populations and chronic care needs.
Without confirmed existence or traction, Duluth Medical Technologies Inc. offers no basis for forward analysis—investors should verify independently via direct outreach or registries.
Medtech trends like Agiliti's 2025 stretcher innovations signal growth in mobility aids and contamination reduction, potentially shaping caregiver efficiency. Expect ecosystem influence from scalable platforms integrating AI (e.g., Alcon's operations) and diagnostics (Quest's subsidiaries), amplifying impact as healthcare consolidates around outcome-driven tech.[1][3][4]
Duluth Medical Technologies Inc. has raised $1.0M in total across 1 funding round.
Duluth Medical Technologies Inc.'s investors include FundRx.
Duluth Medical Technologies Inc. has raised $1.0M across 1 funding round. Most recently, it raised $1.0M Seed in September 2019.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 1, 2019 | $1.0M Seed | FundRx |